SiteOne Therapeutics competitors

SiteOne Therapeutics Competitors include Cannabis Sativa, CTD Holdings, Enanta Pharmaceuticals and Endologix.
Add company...
SiteOne Therapeutics
SiteOne Therapeutics
SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids
Cannabis Sativa
Cannabis Sativa
Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
CTD Holdings
CTD Holdings
CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases.
Enanta Pharmaceuticals
Enanta Pharmaceuticals
Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.
Endologix
Endologix
Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.
Founding Date
Founding Date
2010
Founding Date
2012
Founding Date
1990
Founding Date
1998
Founding Date
1992
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Bozeman, US HQ
Locations
Mesquite, US HQ
Locations
Alachua, US HQ
Locations
Watertown, US HQ
Locations
Irvine, US HQ
Rosmalen, NL
Employees
Employees
N/A
Employees
6200% increase
Employees
456% decrease
Employees
89
Employees
675
Valuation ($)
Valuation ($)
N/A
Valuation ($)
56.8 m
Valuation ($)
35.5 m
Valuation ($)
2 b
Valuation ($)
56.5 m
Twitter followers
Twitter followers
N/A
Twitter followers
107
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
242

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.6k (FY, 2015)
Revenue (est.)
N/A
Revenue (est.)
$206.6m (FY, 2018)
Revenue (est.)
$181.2m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$5.8k (FY, 2015)
Cost of goods
$132.9k (FY, 2017)
Cost of goods
N/A
Cost of goods
$59.8m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
$5.8k (FY, 2015)
Gross profit
N/A
Gross profit
N/A
Gross profit
$121.3m (FY, 2017)
Net income
Net income
N/A
Net income
($7.4m) (FY, 2015)
Net income
($3.8m) (FY, 2017)
Net income
$72m (FY, 2018)
Net income
($66.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 17.8m
Total funding raised
N/A
Total funding raised
$ 1.7m
Total funding raised
$ 9.2m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Cannabis Sativa
HQ
Mesquite, US
Employees
6

Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.

View company
CTD Holdings
HQ
Alachua, US
Employees
4

CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases.

View company
Enanta Pharmaceuticals
HQ
Watertown, US
Employees
89

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.

View company
Endologix
HQ
Irvine, US
Employees
675

Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.

View company